SCHEMBL17322885

SCHEMBL17322885

COC(=O)Cn1nc(-c2ccccc2)c2c(C(F)(F)F)cccc21

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.63
▸ KDM4E B2RXH2 2/20 0.63
▸ SMN1; SMN2 Q16637 2/20 0.63
▸ ALDH1A1 P00352 1/20 0.63
▸ LMNA P02545 1/20 0.63
▸ HPGD P15428 1/20 0.63
▸ HTT P42858 1/20 0.63
▸ MAPT P10636 1/20 0.54
▸ TSHR P16473 1/20 0.53
▸ RORC P51449 4/20 0.46
▸ HSD17B10 Q99714 1/20 0.44
▸ GAA P10253 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ MEN1 O00255 1/20 0.41
▸ ESR1 P03372 1/20 0.39
▸ RET P07949 1/20 0.39
▸ PRKX P51817 1/20 0.39
▸ TAOK1 Q7L7X3 1/20 0.39
▸ HCRTR1 O43613 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17322891 0.83 KMT2A (0.69) KMT2AKDM4ESMN1; SMN2ALDH1A1LMNA
SCHEMBL15631890 0.83 KMT2A (0.65) KMT2AKDM4ESMN1; SMN2ALDH1A1LMNA
SCHEMBL15631842 0.78 KDM4E (0.65) KMT2AKDM4ESMN1; SMN2ALDH1A1LMNA
SCHEMBL15631853 0.78 KMT2A (1.00) KMT2AKDM4ESMN1; SMN2ALDH1A1LMNA
SCHEMBL15631875 0.76 LMNA (0.69) KMT2AKDM4ESMN1; SMN2ALDH1A1LMNA
SCHEMBL17326571 0.76 MAPT (0.71) KMT2AKDM4ESMN1; SMN2ALDH1A1LMNA
SCHEMBL15631891 0.76 KDM4E (0.76) KMT2AKDM4ESMN1; SMN2ALDH1A1LMNA
SCHEMBL17322872 0.76 ALDH1A1 (0.71) KMT2AKDM4ESMN1; SMN2ALDH1A1LMNA
SCHEMBL15631882 0.72 MAPT (0.75) KMT2AKDM4ESMN1; SMN2ALDH1A1LMNA
SCHEMBL15631866 0.72 KMT2A (0.73) KMT2AKDM4ESMN1; SMN2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9738610-B2 Indazole derivatives and uses thereof WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2017-08-22 — — US disclosed
US-9738610-B2 Indazole derivatives and uses thereof WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2017-08-22 — — US disclosed
US-20150353503-A1 INDAZOLE DERIVATIVES AND USES THEREOF WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2015-12-10 — — US disclosed
US-20150353503-A1 INDAZOLE DERIVATIVES AND USES THEREOF WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2015-12-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150353503-A1 INDAZOLE DERIVATIVES AND USES THEREOF CYP11B1, HSP90B1, CYP1B1 KMT2A 4742/4885KDM4E 4525/4885SMN1; SMN2 4794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback